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ABSTRAK
Irama sirkadian dalam tubuh, mempengaruhi variasi tekanan darah baik pada siang dan malam hari, 
sehingga didapatkan pola tekanan darah yang berbeda. Hipertensi nokturnal adalah peningkatan tekanan darah 
>120/70 mmHg pada malam hari akibat terganggunya irama sirkadian, dan berkaitan dengan peningkatan 
kejadian kardiovaskular, serebrovaskular, serta mortalitas pada pasien hipertensi. Hipertensi nokturnal dan 
perubahan pola penurunan tekanan darah, hanya dapat diketahui dengan cara melakukan pemeriksaan tekanan 
darah secara kontinyu selama 24 jam yang dikenal sebagai ambulatory blood pressure measurement (ABPM). 
Kronoterapi, menjadi salah satu strategi dalam menangani pasien dengan hipertensi nokturnal, yaitu dengan 
meminum obat anti hipertensi pada malam hari untuk mendapatkan penurunan tekanan darah yang sesuai 
irama sirkadian untuk meningkatkan kontrol tekanan darah.
Kata kunci: hipertensi nokturnal, pengukuran tekanan darah ambulatori, non-dipping, kronoterapi.
ABSTRACT
The body circardian rhythm affects blood pressure variability at day and night, therefore blood pressure at 
day and night might be different. Nocturnal hypertension is defined as increase of blood pressure >120/70mmHg 
at night, which is caused by disturbed circadian rhythm, and associated with higher cardiovascular and 
cerebrovascular events also mortality in hypertensive patients. Nocturnal hypertension and declining blood 
pressure pattern, can only be detected by continuous examination for 24 hours, also known as ambulatory blood 
pressure measurement (ABPM). Chronotherapy, has become a strategy for managing the hypertensive nocturnal 
patients, by taking hypertensive medication at night to obtain normal blood pressure decrease in accordance 
with the normal circadian rhythm and, improving blood pressure control.
Keywords: nocturnal hypertension, ambulatory blood pressure measurement, non-dipping, chronotherapy.
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INTRODUCTION
Hypertension has been for long time well 
studied as one of the major cardiovascular 
disease risk factor, thus hypertension treatment in 
controlling blood pressure is important to prevent 
cardiovascular disease progression.1 However, 
the diagnosis of nocturnal hypertension tend to 
be missed although it is an important predictor 
of all cause mortality and/or cardiovascular 
mortality.2 Lack of awareness with hypertension 
cause patients to measure their blood pressure 
only during hospital visit. This factor contributed 
to the limited use of ambulatory blood pressure 
measurement (ABPM), and the possibility of 
nocturnal hypertension became overlooked.3 
In this review, we described the definition, 
epidemiology, pathophysiology, clinical 
significance, diagnosis, and anti hypertension 
management of nocturnal hypertension.
DEFINITION
Hypertension is a major independent risk 
factor for the development of cardiovascular 
disease, and its variation at day or night of 
the blood pressure depends on circadian 
rhythm, which is associated with interaction 
of sympathetic nervous system and renin-
angiotensin systems.4 This blood pressure 
variation phenomenon consist of dipping, 
extreme dipping, non dipping and riser or reverse 
dipping. Dipping phenomenon is defined as a 
decrease in systolic nighttime blood pressure 10-
20% from daytime blood pressure and occurs as 
normal physiologic changes. The term “extreme 
dipping” is used when nighttime blood pressure 
decrease more than 20%. Meanwhile, in non 
dipping pattern, the decrease in blood pressure 
is only approximately 0-10% and the increase 
in blood pressure at night is called reverse 
dipping or riser. The latter pattern (non dipping 
and reverse dipping/riser) were associated with 
nocturnal hypertension. Nocturnal hypertension 
is defined as increase of blood pressure >120/70 
mmHg at night.5-7
EPIDEMIOLOGY
As discussed above, the blood pressure 
changes at night was a physiologic changes 
that occurs in healthy individual. However, 
these changes did not occur in some people. 
The non dipping pattern was found higher 
in Chinese, Japanese, and South Africans 
compared in Western and Eastern Europeans 
with the prevalence of 10.9% vs. 6.0%. The 
higher sodium and lower potassium intake 
among Asian than other population might be 
contribute to it.8 In a cohort study of Spanish 
Society of Hypertension Ambulatory Blood 
Pressure Monitoring Registry reported that from 
42,947 hypertensive patients, there were 50.2% 
untreated patients and 40% treated patients had 
dipping pattern. At the same time, there were also 
35% untreated patients and 40% treated patients 
had non dipping pattern.9 Non dipping pattern 
was associated with more severe target organ 
damage from chronic kidney disease (CKD), 
cardiovascular and cerebrovascular disease 
induced by hypertension.10
Non dippers were more prevalent in 
individuals with CKD and diabetic patients. 
Liu et al11 found that non dipping phenomenon 
was commonly found in patients undergoing 
hemodialysis with the prevalence up to 70%. 
The possible mechanism is due to an inadequate 
blood pressure as a consequence of baroreflex 
or autonomic dysfunction in CKD patients, thus 
maintaining more adequate hemodialysis in these 
patients is needed to decrease cardiovascular 
complications. Also, in a study conducted by 
Cuspidi et al, found that non dipping prevalence 
was higher in hypertensive diabetic subjects 
than in hypertensive nondiabetic subjects after 
24 hours ambulatory blood pressure monitoring. 
Renal hemodynamics, blood flow distribution, 
and plasma volume are thought to be affected 
by hyperglycemia state in diabetic patients.12,13
PATHOPHYSIOLOGY OF NOCTURNAL 
HYPERTENSION
Many factors were postulated in disrupting 
the circadian rhythm, which in turn lead to 
attenuation of nocturnal blood pressure lowering 
phenomenon. The causes of abnormal circadian 
rhythm of blood pressure can be divided to 
hormonal metabolic factors and external factors 
such as smoking or aging. Some disease are 
implicated in the disruption, such as diabetes 
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mellitus, metabolic syndrome, chronic kidney 
disease, and obstructive sleep apnea (OSA).14 In 
this paper, we described the two most reported 
mechanisms of nocturnal hypertension, which 
were imbalance of nocturnal autonomic nervous 
system and limited sodium metabolism by 
kidneys.
Imbalance of Nocturnal Autonomic Nervous 
System Activation
In physiologic state, blood pressure levels 
is fluctuated along the day with peak in early 
morning and low during sleeping. Circadian 
rhythm is one of the contributors of the fluctuation 
which controlled from suprachiasmatic nuclei 
(SCN) of the anterior hypothalamus. Circadian 
rhythm mainly influenced by autonomic nervous 
system.15 In general, autonomic nervous system 
composed of sympathetic and parasympathetic 
nerves, which keep in balance to maintain 
physiologic state. Over dominance of sympathetic 
activation was postulated as the cause of 
nocturnal hypertension and attenuated the blood 
pressure dipping. Vardhan et al reported that, 
patients with obstructive sleep apnea (OSA) were 
having higher catecholamines plasma and urinary 
levels compared with control. This findings were 
correlated with hypertension in patient with 
OSA.16 Nielsen et al17, found that low degree of 
blood pressure dipping were related to sustained 
adrenergic activity which reflected by higher 
noradrenaline level and lead to decreased the 
peripheral vasodilatation capacity. Doxazosin, an 
alpha-1 adrenergic blocker drug, will effectively 
block the sympatethics activity which in turn 
lower the blood pressure while sleeping.18 These 
studies showed that non dipping phenomenon 
is caused by sympatethics system over activity.
Limited Sodium Metabolism
Kidneys have a role in maintaining blood 
pressure, regulated by renin-angiotensin-
aldosteron system and influenced by circadian 
rhythm. Non dipping patients are thought to 
be related with impaired capacity of kidneys 
to excrete sodium during daytime or increased 
tubular sodium reabsorption which was 
commonly caused by hyperaldosteronism.19 This 
theory was supported by data that the prevalence 
of non-dipper was increased in patient with low 
glomerular filtration rate (GFR).20 Wang et al21 
reported among 540 Chinese CKD patients, total 
of 21.9% patients were riser, 36.1% patients were 
dipper, and 42% of patients were non-dipper.21 
However, increased daily salt intake also found 
to be related with nocturnal hypertension. 
Kidneys will compensate high sodium intake 
by enhancing natriuresis during the night. Thus, 
blood pressure will remain elevated until kidneys 
succeed in reducing excess sodium.22,23
CLINICAL IMPLICATIONS OF NOCTURNAL 
HYPERTENSION
Nocturnal hypertension phenomenon results 
in several clinical implications that have to be 
taken into consideration to predict complications 
and approach strategy to treat every individual 
with hypertension. There have been many 
studies conducted about circadian patterns 
and its clinical implications, especially those 
associated with cardiovascular, cerebrovascular, 
and renal diseases. Fagard et al24, mentioned that 
cardiovascular complication in subject with non 
dipping circadian pattern is higher compared to 
subjects with dipping pattern. This statement is 
also supported by one of the studies that showed 
increasing 10 mmHg of nighttime systolic 
blood pressure would rise 35% possibility of 
cardiovascular risk in diabetic population.25
The negative effect of cardiac function 
was described by Verdecchia et al26. that non 
dipping group had greater risk of left ventricular 
hypertrophy (LVH) compared with dipping 
group. Groups with dipping circadian pattern 
had LVH risk at about 4%, while the risk of 
group with non dipping pattern increased to 
15%. The thickening of carotid intima (>0.8 
mm) also found higher in non dipping pattern 
than dipping, that will lead to atherosclerosis. 
OPERA study showed on their population based 
cohort study of 900 middle aged individuals, that 
mean carotid intima media thickness were higher 
in non-dipper (90 mm) compared to dipper (80 
mm).27 The association between carotid intima 
thickening and atherosclerosis plaque formation 
is supported by Salvetti et al28. The results of 
ultrasonography showed that thickening of 
carotid intima and formation of plaque presence 
were 55% and 56% respectively in uncontrolled 
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hypertensive patients with non dipping circadian 
pattern, whereas in dipping circadian pattern 
were 24% and 33% respectively.
Persons who have high blood pressure in the 
night, which includes reverse dipping and non 
dipping had an increased risk of intracerebral 
hemorrhage (ICH). Sun et al6, found that 
probability of silent ICH in non dipping and 
reverse dipping group was 50.8%. Meanwhile, 
Tsivgoluis et al conducted a research on patients 
with ICH, and found that 74.4% of the patients 
with ICH were non dippers, while 43.8% of the 
patients were dippers.29 Another study by Ma 
et al30 showed, that several subjects with non 
dipping pattern had silent cerebral infarct. Non 
dipping are associated with lacunar cerebral 
infarct eventwhich may leads to decline in verbal 
memory function.31
Kidney failure was also considered as 
another important clinical implication of the non 
dipping circadian pattern, reflected by presence 
of microalbuminuria and decreasing GFR. 
Kastarinen et al did a research of renal function 
on 460 subjects where 18.7% of the study 
population were non dipper. The mean eGFR 
of non dippers in this study were significantly 
lower compared with a mean eGFR in dipper 
patients.32 Meanwhile, Afsar et al33 compared 
patterns of non dipping and 24 hour urinary 
albumin excretion (UAE) in 158 hypertensive 
patients (104 dippers; 54 non dippers). Among 
patients in the non dipper group, 17 patients had 
microalbuminuria, while only 9 patients in dipper 
group had microalbuminuria (P<0.0001). The 
median UAE of dipper group was significantly 
lower (5.25 mg/day) when compared with non 
dipper group (23 mg/day).
SIGNIFICANCE OF AMBULATORY BLOOD 
PRESSURE MONITORING IN NON DIPPING 
HYPERTENSIVE PATIENT
There are several modalities of measuring 
blood pressure, which is divided into two 
categories, the clinic based measurement 
(auscultatory method, oscillometric method) 
and non clinic-based measurement (home blood 
pressure monitoring, ABPM).34 ABPM itself has 
gained popularity as an alternative to traditional 
method for measuring blood pressure in clinical 
setting.35 In the ABPM technique, the patient 
wears a portable blood pressure measuring 
device for a certain period (usually 24 h). This 
periodically measures blood pressure (every 
15–30 min during the day and every 30–60 
min overnight) automatically and may provide 
information of blood pressure during normal 
daytime activities and importantly during 
sleep.36,37 The term ‘nocturnal hypertension’ 
or ‘non dipping’ pattern as described in above 
section become an important phenomenon to be 
considered by all clinicians and it can only be 
identified by 24 hour ABPM or other methods of 
recording the sleep blood pressure.38,39
Many studies compared ABPM and clinic-
based measurement and concluded that ABPM 
is more superior in predicting cardiovascular 
event or other prognostic factor. ABPM may also 
reduce the incidence of white-coat effect and 
masked hypertension that were not detected in 
clinic-based measurement, and also predict all-
cause mortality especially due to cardiovascular 
event than awake or clinic blood pressure.24,34,40 
The results of the study showed that patients 
with an absence of normal dipping has higher 
mortality than the dipping one. The pattern 
of dipping that was detected will add clinical 
predictive information and further reinforcing 
the use of ambulatory monitoring in patient 
management.40 Therefore, importance of 
nocturnal hypertension or ‘non dipping pattern’ 
of blood pressure strengthens the need for 24 
hours ABPM.
T H E  I M P R O V E D  S T R A T E G Y  I N 
HYPERTENSION MANAGEMENT
Standard Treatment of Hypertension
Nowadays, there are many different classes 
of antihypetensive drugs, such as diuretics, 
angiotensin-converting enzyme (ACE) inhibitor, 
angiotensin II-receptor-blockers (ARBs), 
β-blocker, and calcium antagonist, that have 
been used for the intitiation and maintenance 
of antihypertensive treatment. Generally, a 
long-acting antihypertensive drug with 24 hours 
duration is used as a initial standard treatment of 
hypertensive patients in order to maintain blood 
pressure variability and adherence to therapy.41,42 
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However, antihypertensive drugs used once 
daily are rarely effective from the morning 
dosing until the following morning. Many of 
the hypertensive patients, especially non dipper 
patients on standard antihypertensive drugs still 
have raised blood pressure on the morning. It is 
because the effect of antihypertensive drugs on 
the diurnal variation of blood pressure, depends 
not only on the mechanism of action of the drugs, 
but also on the time of administration, and the 
pharmacokinetics and pharmacodymamics of 
the drug.43
In this regard, choosing the optimal timing 
for drug administration, especially a single dose 
antihypertensive drug, such as several kind of 
ACE inhibitor, ARB, or calcium antagonist 
should be considered. Also, we have discussed 
that the blood pressure (BP) is regulated by many 
different systems and its activity vary throughout 
the day. As drugs are developed that selectively 
block these systems, the reduction on the BP may 
not be consistent over 24 hours.4,44
Chronotherapy: Improving the Hypertension 
Management
Chronotherapy is defined as administering 
drug while considering the optimal dosing 
time in purpose to enhance drugeffectiveness 
and tolerance. In hypertension, chronotherapy 
defined as taking hypertensive medication at 
night to obtain normal BP decrease in line with 
circadian rhythms, reduce the morbidity and 
mortality.45,46
The  MAPEC s tudy  compared  the 
administration time between morning dose 
(taking all prescribed drugs in the morning) and 
bedtime doses (taking more than one drug at 
bedtime), and concluded that after a mean follow 
up of 5.6 years in 2156 subjects, the bedtime 
dose achieved better overall BP control. Also, 
subjects taking more than one drug at bedtime 
showed significantly lower relative risk of total 
cardiovascular disease events, compared to those 
taking all drugs in the morning. The prevalence 
of non-dipping significantly reduced in those 
receiving medication in the bedtime (34% 
vs. 62%) and higher prevalence of controlled 
ambulatory BP (62% vs. 53%).45
The possibility to achieve better BP control 
using telmisartan administered at bedtime was 
assessed in a study, in which telmisartan 80 
mg given in 215 patients randomized to take 
the drug in the morning or bedtime. After 12 
weeks of treatment, the reduction of BP was 
similar for both groups. However, subjects 
taking bedtime dose had reduced prevalence 
for non-dipper by 76%, without loss in 24 hour 
efficacy of telmisartan.47 Similar results were 
found in other studies, in which olmesartan or 
valsartan taken at night provided 24 hours BP 
reduction while improving nocturnal BP fall 
more significantly than morning dosing, thus 
reducing the prevalence of non dipper.48,49
The use of chronotherapy in other 
hypertensive drugs regimens had shown similar 
beneficial effects. Bedtime dosing of ramipril 
in at least two different studies were found 
to be effective in achieving nocturnal BP 
regulation.50,51 The role of chronotherapy in 
nifedipine GITS (Gastrointestinal-Therapeutic-
System) formulation and amlodipine as calcium 
channel blocker class drugs also showed greater 
reduction of 24-hours ABPM and greater BP 
reduction at night compared with morning 
dosing.52,53
A chronotherapy trial using combination 
antihypertensive drug also has been conducted 
by Hermida et al54, using valsartan/amlodipine 
combination in 203 hypertensive subjects, and 
resulted that BP-lowering efficacy was highest 
when both antihypertensive drugs ingested 
at bedtime, compared to both ingested on 
awakening, or either of the drugs ingested on 
awakening and the other at bedtime. Moreover, 
chronotherapy was found to have useful effect 
in treatment of resistant hypertension. In a study 
of 250 patients with resistant hypertension that 
received three hypertensive drugs, ambulatory 
BP reduced by 9.4/6.0 mmHg when one of 
the drugs was administered at bed time. The 
percentage of dippers increased from 16% to 
57% after 12 weeks of administering one drug 
at bedtime.55
CONCLUSION
As conclusion, identifying the nocturnal 
hypertension as well dipping or non dipping status 
of patients are important for aiding the decision 
on the necessity of chronotherapy, withdrawal 
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or reduction of unnecessary medication, and 
monitoring hypertension treatment. Taking 
the antihypertensive medication in the night 
significantly improves the dipping pattern of 
hypertensive patient, thus chronotherapy is a 
improved strategy in hypertension management.
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